{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:13:43Z","timestamp":1789586023598,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015308","name":"Stephenson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.xphs.2020.02.016","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T11:19:55Z","timestamp":1582802395000},"page":"2000-2008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vaginal Suppositories Containing SHetA2 to Treat Cervical Dysplasia: Pharmacokinetics of Daily Doses and Preliminary Safety Profile"],"prefix":"10.1016","volume":"109","author":[{"given":"Sanjida","family":"Mahjabeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manolya Kukut","family":"Hatipoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley D.","family":"Kosanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garcia-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris M.","family":"Benbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucila","family":"Garcia-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2020.02.016_bib1","first-page":"240","article-title":"Cervical cancer: a preventable death","volume":"2","author":"Nour","year":"2009","journal-title":"Rev Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.xphs.2020.02.016_bib2","doi-asserted-by":"crossref","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.xphs.2020.02.016_bib3","first-page":"378","article-title":"Cervical dysplasia treatment: key issues for developing countries","volume":"30","author":"Bishop","year":"1996","journal-title":"Bull Pan Am Health Organ"},{"issue":"6","key":"10.1016\/j.xphs.2020.02.016_bib4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.cdp.2003.09.004","article-title":"Follow-up care of women with an abnormal cytology in a low-resource setting","volume":"27","author":"Gage","year":"2003","journal-title":"Cancer Detect Prev"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.016_bib5","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.xphs.2020.02.016_bib6","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1128\/jvi.68.7.4358-4368.1994","article-title":"Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice","volume":"68","author":"Arbeit","year":"1994","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.016_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/AOG.0b013e31825bc6e8","article-title":"Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial","volume":"120","author":"Grimm","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xphs.2020.02.016_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12885-016-2187-3","article-title":"TOPical Imiquimod treatment of high-grade cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial","volume":"16","author":"Koeneman","year":"2016","journal-title":"BMC Cancer"},{"issue":"4 Part 2","key":"10.1016\/j.xphs.2020.02.016_bib9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0190-9622(86)70240-5","article-title":"Clinical experience with topical tretinoin in the treatment of cervical dysplasia","volume":"15","author":"Meyskens","year":"1986","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"16","key":"10.1016\/j.xphs.2020.02.016_bib10","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1158\/0008-5472.CAN-09-0913","article-title":"Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells","volume":"69","author":"Masamha","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.xphs.2020.02.016_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s10637-008-9175-7","article-title":"Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in\u00a0vitro and in\u00a0vivo","volume":"27","author":"Myers","year":"2009","journal-title":"Invest New Drugs"},{"issue":"3","key":"10.1016\/j.xphs.2020.02.016_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/gyno.2001.6196","article-title":"Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus","volume":"81","author":"Bae","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.xphs.2020.02.016_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10637-005-2901-5","article-title":"Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists","volume":"23","author":"Benbrook","year":"2005","journal-title":"Invest New Drugs"},{"issue":"7","key":"10.1016\/j.xphs.2020.02.016_bib14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/93.7.516","article-title":"Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma","volume":"93","author":"Guruswamy","year":"2001","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.xphs.2020.02.016_bib15","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1073\/pnas.1231422100","article-title":"Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis","volume":"100","author":"Mic","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.016_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mrgentox.2012.03.009","article-title":"Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen","volume":"746","author":"Doppalapudi","year":"2012","journal-title":"Mutat Res"},{"issue":"3","key":"10.1016\/j.xphs.2020.02.016_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/01480545.2012.710632","article-title":"Oral toxicity and pharmacokinetic studies of SHetA2, a new chemopreventive agent, in rats and dogs","volume":"36","author":"Kabirov","year":"2013","journal-title":"Drug Chem Toxicol"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.016_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/acs.molpharmaceut.7b01062","article-title":"SHetA2 dry powder aerosols for tuberculosis: formulation, design, and optimization using quality by design","volume":"15","author":"Ibrahim","year":"2018","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.016_bib19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.xphs.2017.09.018","article-title":"Optimization of a vaginal suppository formulation to deliver SHetA2 as a novel treatment for cervical dysplasia","volume":"107","author":"Mahjabeen","year":"2018","journal-title":"J\u00a0Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2020.02.016_bib20","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/j.xphs.2018.08.024","article-title":"Pharmacokinetics and pharmacodynamics of escalating doses of SHetA2 after vaginal administration to mice","volume":"107","author":"Mahjabeen","year":"2018","journal-title":"J\u00a0Pharm Sci"},{"issue":"Suppl 8","key":"10.1016\/j.xphs.2020.02.016_bib21","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1016\/j.vaccine.2013.07.026","article-title":"Comprehensive control of human papillomavirus infections and related diseases","volume":"31","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.016_bib23","first-page":"13","article-title":"Standardization of the Whitten effect to induce susceptibility to Neisseria gonorrhoeae in female mice","volume":"40","author":"Dalal","year":"2001","journal-title":"Contemp Top Lab Anim Sci"},{"key":"10.1016\/j.xphs.2020.02.016_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejpb.2018.07.004","article-title":"Influence of the estrus cycle of the mouse on the disposition of SHetA2 after vaginal administration","volume":"130","author":"Mahjabeen","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2020.02.016_bib25","first-page":"4389","article-title":"Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification","volume":"67","author":"McLean","year":"2012","journal-title":"J\u00a0Vis Exp"},{"issue":"4","key":"10.1016\/j.xphs.2020.02.016_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jpba.2019.03.037","article-title":"Development and validation of a reverse phase HPLC method for SHetA2 in gynecological tissues","volume":"170","author":"Hatipoglu","year":"2019","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2020.02.016_bib27","series-title":"Draft Guidance on Miconazole Nitrate Services","year":"2009"},{"issue":"7","key":"10.1016\/j.xphs.2020.02.016_bib28","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1023\/A:1011990413450","article-title":"Evaluation of a Cmin and a normalized Cmin method for the confirmation of steady-state in bioequivalence studies","volume":"15","author":"Jackson","year":"1998","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.016_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2005","journal-title":"J\u00a0Control Release"},{"issue":"16","key":"10.1016\/j.xphs.2020.02.016_bib30","first-page":"4862","article-title":"Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis","volume":"63","author":"Riley","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.xphs.2020.02.016_bib31","series-title":"The Guide to Investigation of Mouse Pregnancy","first-page":"85","article-title":"Reproductive tract changes during the mouse estrous cycle","author":"Bertolin","year":"2014"},{"issue":"4","key":"10.1016\/j.xphs.2020.02.016_bib32","doi-asserted-by":"crossref","first-page":"e35538","DOI":"10.1371\/journal.pone.0035538","article-title":"Mouse estrous cycle identification tool and images","volume":"7","author":"Byers","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2020.02.016_bib33","series-title":"Atlas of Laboratory Mouse Histology","author":"Conti","year":"2004"},{"key":"10.1016\/j.xphs.2020.02.016_bib34","series-title":"Histological Atlas of the Laboratory Mouse","author":"Gude","year":"1982"},{"issue":"12","key":"10.1016\/j.xphs.2020.02.016_bib35","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/j.1552-4604.1993.tb03921.x","article-title":"Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single- and double-peak phenomena in the plasma profiles","volume":"33","author":"Charman","year":"1993","journal-title":"J\u00a0Clin Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2020.02.016_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0090-9556(24)15233-6","article-title":"A\u00a0double-peak phenomenon in the pharmacokinetics of alprazolam after oral administration","volume":"27","author":"Wang","year":"1999","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.xphs.2020.02.016_bib37","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/1940-6207.CAPR-13-0171","article-title":"Chemoprevention of colon and small intestinal tumorigenesis in APC(min\/+) Mice by SHetA2 (NSC721689) without toxicity","volume":"6","author":"Benbrook","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.xphs.2020.02.016_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-6-24","article-title":"The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention","volume":"6","author":"Alao","year":"2007","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.016_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1940-6207.CAPR-08-0218","article-title":"Retinoid chemoprevention trials: Cyclin D1 in the crosshairs","volume":"2","author":"Freemantle","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"issue":"12","key":"10.1016\/j.xphs.2020.02.016_bib40","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/mc.20204","article-title":"Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis","volume":"45","author":"Yamamoto","year":"2006","journal-title":"Mol Carcinog"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.016_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ilar.41.2.87","article-title":"Humane endpoints and cancer research","volume":"41","author":"Wallace","year":"2000","journal-title":"ILAR J"},{"issue":"3","key":"10.1016\/j.xphs.2020.02.016_bib42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.18433\/J3HP41","article-title":"Strategies to prolong the intravaginal residence time of drug delivery systems","volume":"12","author":"Baloglu","year":"2009","journal-title":"J\u00a0Pharm Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2020.02.016_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/mmy\/myv017","article-title":"A\u00a0randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis","volume":"53","author":"Li","year":"2015","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.016_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1185\/030079904X18018","article-title":"Safety and efficacy of bedtime versus daytime administration of the miconazole nitrate 1200 mg vaginal ovule insert to treat vulvovaginal candidiasis","volume":"21","author":"Barnhart","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.016_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000371759","article-title":"Miconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis","volume":"80","author":"Fan","year":"2015","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"10.1016\/j.xphs.2020.02.016_bib46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/15246090050020745","article-title":"Single-dose miconazole nitrate vaginal ovule in the treatment of vulvovaginal candidiasis: two single-blind, controlled studies versus miconazole nitrate 100 mg cream for 7 days","volume":"9","author":"Upmalis","year":"2000","journal-title":"J\u00a0Womens Health Gend Based Med"},{"key":"10.1016\/j.xphs.2020.02.016_bib47","article-title":"Hematoxylin and eosin staining of tissue and cell sections","volume":"2008","author":"Fischer","year":"2008","journal-title":"CSH Protoc"},{"key":"10.1016\/j.xphs.2020.02.016_bib48","series-title":"Biology of the Laboratory Mouse","year":"1966"},{"key":"10.1016\/j.xphs.2020.02.016_bib49","series-title":"Embryology Estrous Cycle","author":"Hill","year":"2020"},{"issue":"4","key":"10.1016\/j.xphs.2020.02.016_bib50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/026119291103900403","article-title":"Vaginal irritation models: the current status of available alternative and in\u00a0vitro tests","volume":"39","author":"Costin","year":"2011","journal-title":"Altern Lab Anim"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.016_bib51","first-page":"1","article-title":"Detecci\u00f3n de inmunoglobulina G en sueros, tejidos y estractos placentarios porcinos","volume":"5","author":"Koncurat","year":"2003","journal-title":"Cienc Vet"},{"key":"10.1016\/j.xphs.2020.02.016_bib52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13567-015-0241-9","article-title":"A\u00a0review of the human vs. porcine female genital tract and associated immune system in the perspective of using minipigs as a model of human genital Chlamydia infection","volume":"46","author":"Lorenzen","year":"2015","journal-title":"Vet Res"},{"key":"10.1016\/j.xphs.2020.02.016_bib53","series-title":"Biotecnolog\u00eda de la Reproducci\u00f3n","first-page":"93","article-title":"Transporte esperm\u00e1tico","author":"Palma","year":"2001"},{"issue":"7","key":"10.1016\/j.xphs.2020.02.016_bib54","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1128\/AAC.04954-14","article-title":"The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides","volume":"59","author":"Holt","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920301167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920301167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:29:39Z","timestamp":1758360579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920301167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0022354920301167"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.02.016","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginal Suppositories Containing SHetA2 to Treat Cervical Dysplasia: Pharmacokinetics of Daily Doses and Preliminary Safety Profile","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}